New England Journal piece on HPV Vaccines
Judging from the early traffic to our site from search engines, it's clear that there is significant interest in the ethics of HPV vaccines. As we've written previously here, we share your interest and expect the topic to explode this spring when key decisions and recommendations from government committees are anticipated. We'll be monitoring developments closely and expect to post often on this topic, likely more frequently than on any other.
In the meantime, the current issue of the New England Journal has this piece (for free!) that sets the stage for the months ahead. It covers virtually identical terrain as our earlier post on HPV vaccines (likely because we both based our reviews on the same presentations at last month's ACIP meeting). Nevertheless, the piece is an excellent, comprehensive look at where we are and where we're headed with HPV vaccines. It is well worth a read.
In the meantime, the current issue of the New England Journal has this piece (for free!) that sets the stage for the months ahead. It covers virtually identical terrain as our earlier post on HPV vaccines (likely because we both based our reviews on the same presentations at last month's ACIP meeting). Nevertheless, the piece is an excellent, comprehensive look at where we are and where we're headed with HPV vaccines. It is well worth a read.








